comparemela.com

Latest Breaking News On - Guangzhou kingmed diagnostics group co ltd - Page 3 : comparemela.com

Global Clinical In Vitro Diagnostic Medical Laboratory Services Market Report 2021: Clinical Labs Under Pressure as Covid Pandemic Closes Healthcare Operation

China science, technology news summary -- June 2

China s medical firm uses drone to deliver biological samples

China s medical firm uses drone to deliver biological samples Xinhua 02 Jun 2021, 02:05 GMT+10 GUANGZHOU, June 1 (Xinhua) A multi-rotor drone carrying biological samples took off from a hospital in south China s megacity of Guangzhou on Monday to replace road transport for the testing delivery in Guangzhou KingMed Diagnostics Group Co., Ltd, a Chinese medical diagnostic testing company. With its highest speed of 50 km per hour, the drone spent ten minutes completing the delivery, far less than the 30 minutes it takes with a vehicle. Liu Weimin, manager of the logistics management center of KingMed Diagnostics, said that drones usually carry a weight of less than 5 kg, which is suitable for transporting biological samples.

Tibet welcomes its first third-party clinical-testing institution - China News

2021-04-15 12:35:49 GMT2021-04-15 20:35:49(Beijing Time) Xinhua English LHASA, April 15 (Xinhua) Southwest China s Tibet Autonomous Region saw its first third-party clinical-testing institution open for business on Thursday. The Tibet KingMed Laboratory, based in the regional capital Lhasa, enables people in Tibet to enjoy the same high-quality medical-testing services found in more developed areas. The new laboratory is subordinated to the Guangzhou KingMed Diagnostics Group Co., Ltd. (KingMed Diagnostics) and is part of Guangdong Province s effort to support the development of health services in Tibet. The laboratory is equipped with a Polymerase Chain Reaction (PCR) laboratory and a pathological diagnosis laboratory, focusing on screening, testing, pathological diagnosis services, and public-health services for diseases such as the COVID-19 epidemic and viral hepatitis.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.